MARKET COMPOSITE
Market TodayThemes and Stocks SummaryThematic Stock SearchDaily Refresh Schedule
CLRB - Cellectar Biosciences Inc
$2.06
-0.08(-3.97%)8:28:57 PM 2/24/2021
Cellectar Biosciences, Inc., a clinical stage biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for the treatment of cancer. Its lead phospholipid drug conjugate (PDC) candidate is CLR 131, which is in Phase II clinical study in patients with relapsed or refractory (R/R) multiple myeloma (MM) and a range of B-cell malignancies, as well as in Phase I clinical study for R/R MM. The company also develops CLR 1900, a PDC chemotherapeutic program that is targeted to treat solid tumors. It has collaborative PDC programs with Pierre Fabre to develop CLR 1800 Series; Avicenna Oncology GMBH to develop CLR 2000 Series; Onconova Therapeutics, Inc. to develop CLR 2100 and 2200 Series; and Orano Med to develop novel PDCs. The company was formerly known as Novelos Therapeutics, Inc. and changed its name to Cellectar Biosciences, Inc. in February 2014. Cellectar Biosciences, Inc. was founded in 2002 and is headquartered in Florham Park, New Jersey.
Stock Chart

Short Volume Ratio = Short Volume / All Volume. Source of Short Volume data comes from 

Finra

Moving Average Convergence/Divergence oscillator (MACD) is one of the simplest and most effective momentum indicators available.

Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. RSI oscillates between zero and 100. According to Wilder, RSI is considered overbought when above 70 and oversold when below 30.

Summary:

  • Volatility is at a recent 2 week high. A high volatility of stock movement indicates uncertainty.
Stock Statistics
MarketCap95.9M
PE Ratio
PEG Ratio
P/B3.9
P/S (ttm)
Earning Growth (QoQ)
Revenue Growth (QoQ)
Short %5%
Held by Institutions %24%
1 Day Vol Adjusted Return-1.2
1 Month Vol Adjusted Return1.7
3 Month Vol Adjusted Return10.7
6 Month Vol Adjusted Return9.9
20 Days SMA Price ZScore-0.4
50 Days SMA Price ZScore-0.1
12 -26 Days PPO4.0
1 Month Average Short Volume Ratio46.5
1 Day Volume Change ZScore1.2
1 Month Daily Vol5.3
Related Topics
leak data

Related Topics

Peers

Related Peers

Stock news